amfAR, The Foundation for AIDS Research

Issue Brief: The Expanded Mexico City Policy: Implications for the Global Fund

On January 23, 2017, President Trump signed a presidential memorandum reinstating the Mexico City Policy (MCP) and directing the Secretary of State to expand it to apply to all United States Global Health Assistance (U.S. GHA). The Expanded Mexico City Policy (EMCP or the Policy), which became effective in May 2017, restricts non-U.S.-based or foreign nongovernmental organizations (fNGOs) from receiving U.S. GHA if they perform, counsel on, or refer for abortion, or advocate for its liberalization outside of limited exceptions.1 The EMCP restrictions apply only to fNGOs, meaning that U.S.-based organizations and multilateral institutions such as the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund or GF) are formally exempt from the Policy. However, because EMCP restrictions apply to the organization’s activities as a whole while receiving U.S. GHA, private and multilateral investments can be impacted when implementing partner networks overlap. Indeed, it is common for the Global Fund and the U.S. government (USG) to fund the same NGO, which has implications for that prime recipient as well as its sub-recipients. This brief examines the effects of the EMCP on the Global Fund, specifically quantifying the proportion of Global Fund investments that are subject to the Policy globally.

Download the full issue brief here or click the image below.

For the Appendix including the full set of country data, click here.